IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
The Evolving Role of Pharmacovigilance and Drug Safety: The Way Forward for Bangladesh

Author: DR HAQUE, ASADUL MAZID HELALI, MD. JALALUDDIN IQBAL, MD. ZAKIRUL ISLAM, MAINUL HAQUE
Abstract: Adverse drug reaction (ADRs) is a major public health issue and safety of drugs is a major concern particularly among children, pregnant women, and the elderly. Every society has the right to be protected against such odds. There are multiple methods for detecting the ADRs at different stages of drug development and also in the market life of a new drug. Single system alone is not sufficient to cover all the demands. Therefore multiple methods are needed for observing and quantifying the ADRs. Monitoring of ADRs by applying well developed IT enabled system in primary and secondary health care also can be an effective measure. ADRs should be taken into account more seriously and critically as often they are life threatening and a burden to the patient. Thus more effort should be put into making methods available for detection of ADRs specially in post-marketing stage of a drug and only then it will be possible to ameliorate the risk-benefit ratio of a treatment. While major advancements of the discipline of pharmacovigilance have taken place in the West, not much has been achieved in Bangladesh. A number of clinical trials and studies are currently ongoing in Bangladesh which necessities an immense needs to understand and implement pharmacovigilance. In Bangladesh, the mindset of people working in regulatory agency and the Bangladesh Pharmaceutical companies needs to change, regarding pharmacovigilance.
Keyword: Pharmacovigilance, Drug-Safety, Bangladesh
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free